Novel insights into the development of T-cell acute lymphoblastic leukemia

Current Hematologic Malignancy Reports

Volumn 2, Issue 3, 2007, Pages 176-182

  Staal, Frank J T ^a   Van Dongen, Jacques J M ^b   Langerak, Anton W ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GAMMA SECRETASE INHIBITOR; IMATINIB; MYC PROTEIN; NOTCH RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; T LYMPHOCYTE RECEPTOR; WNT PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; GASTROINTESTINAL SYMPTOM; GENE OVEREXPRESSION; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW; T CELL LEUKEMIA; THYMOCYTE;

ADULT; ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; DRUG DELIVERY SYSTEMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LYMPHOPOIESIS; MICE; ONCOGENE PROTEINS, FUSION; ONCOGENES; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NOTCH; T-LYMPHOCYTES; THYMUS GLAND; TRANSLOCATION, GENETIC; WNT PROTEINS;

EID: 34547766674     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-007-0024-0     Document Type: Review

References (50)

1. Blom B, Spits H: Development of human lymphoid cells. Annu Rev Immunol 2006, 24:287-320.
2. Weerkamp F, Pike-Overzet K, Staal FJ: T-sing progenitors to commit [review]. Trends Immunol 2006, 27:125-131.
3. Weerkamp F, van Dongen JJ, Staal FJ: Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia. Leukemia 2006, 20:1197-1205.
4. Dik WA, Pike-Overzet K, Weerkamp F, et al.: New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 2005, 201:1715-1723.
5. Weerkamp F, de Haas EF, Naber BA, et al.: Age-related changes in the cellular composition of the thymus in children. J Allergy Clin Immunol 2005, 115:834-840.
6. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I, et al.: The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol 2002, 117:380-389.
7. Asnafi V, Beldjord K, Boulanger E, et al.: Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003, 101:2693- 2703.
8. .• Soulier J, Clappier E, Cayuela JM, et al.: HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005, 106:274-286. Together with reference 9, an extensive microarray profiling study of T-ALL cases, leading to classifications based on comparisons with normal thymocyte development.
9. Ferrando AA, Neuberg DS, Staunton J, et al.: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002, 1:75-87.
10. Ferrando AA, Armstrong SA, Neuberg DS, et al.: Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 2003, 102:262-268.
11. Dik WA, Brahim W, Braun C, et al.: CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 2005, 19:1948-1957.
12. Pike-Overzet K, de Ridder D, Weerkamp F, et al.: Gene therapy: is IL2RG oncogenic in T-cell development? [comment]. Nature 2006, 443:E5; discussion E6-E7.
13. • Pike-Overzet K, de Ridder D, Weerkamp F, et al.: Ectopic retroviral expression of LMO2, but not IL2R7gamma;, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy. Leukemia 2007, 21:754-763. Detailed investigation into the effects of LMO2 overexpression on development of all human leukocyte lineages.
14. Langenau DM, Feng H, Berghmans S, et al.: Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 2005,102:6068-6073.
15. Robb L, Begley CG: The SCL/TAL1 gene: roles in normal and malignant haematopoiesis. Bioessays 1997, 19:607-613.
16. O'Neil J, Shank J, Cusson N, et al.: TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 2004, 5:587-596.
17. Hofmann TJ, Cole MD: The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation. Oncogene 1996, 13:617-624.
18. Chen J, Jette C, Kanki JP, et al.: NOTCH1-induced T-cell leukemia in transgenic zebrafish. Leukemia 2007, 21:462-471.
19. Dik WA, Nadel B, Przybylski GK, et al.: Different chromosomal breakpoints impact level of LMO2 expression in T-ALL. Blood 2007, In press.
20. Finger LR, Harvey RC, Moore RC, et al.: A common mechanism of chromosomal translocation in T- and B-cell neoplasia. Science 1986, 234:982-985.
21. Przybylski GK, Dik WA, Wanzeck J, et al.: Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005, 19:201-208.
22. • Grabher C, von Boehmer H, Look AT: Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006, 6:347-359. Excellent review on the role of Notch1 mutations in the development of T-ALL.
23. Graux C, Cools J, Melotte C, et al.: Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004, 36:1084-1089.
24. Grutz GG, Bucher K, Lavenir I, et al.: The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J 1998, 17:4594-4605.
25. Ellisen LW, Bird J, West DC, et al.: TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991, 66:649-661.
26. Capobianco AJ, Zagouras P, Blaumueller CM, et al.: Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2. Mol Cell Biol 1997, 17:6265-6273.
27. Wolfer A, Bakker T, Wilson A, et al.: Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8 T cell development. Nat Immunol 2001, 2:235-241.
28. Radtke F, Wilson A, Stark G, et al.: Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999, 10:547-558.
29. Radtke F, Wilson A, Mancini SJ, MacDonald HR: Notch regulation of lymphocyte development and function. Nat Immunol 2004, 5:247-253.
30. Weerkamp F, Luis TC, Naber BA, et al.: Identification of Notch target genes in uncommitted T-cell progenitors: no direct induction of a T-cell specific gene program. Leukemia 2006, 20:1967-1977.
31. Allman D, Karnell FG, Punt JA, et al.: Separation of Notch1 promoted lineage commitment and expansion/ transformation in developing T cells. J Exp Med 2001, 194:99-106.
32. • Weng AP, Ferrando AA, Lee W, et al.: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269-271. Seminal paper demonstrating that Notch1 mutations are causally involved in the development of T-ALL.
33. Palomero T, Lim WK, Odom DT, et al.: NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A 2006, 103:18261-18266.
34. Bellavia D, Campese AF, Checquolo S, et al.: Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci U S A 2002, 99:3788-3793.
35. Talora C, Cialfi S, Oliviero C, et al.: Cross talk among Notch3, pre-TCR, and Tall in T-cell development and leukemogenesis. Blood 2006, 107:3313-3320.
36. Palomero T, McKenna K, O'Neil J, et al.: Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. Leukemia 2006, 20:1963-1966.
37. • Vilimas T, Mascarenhas J, Palomero T, et al.: Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007, 13:70-77. Demonstration that NF-κB activation and Notch1 mutations synergistically activate an oncogenic gene program in T-ALL.
38. • Staal FJ, Clevers HC: WNT signalling and haematopoiesis: a WNT-WNT situation [review]. Nat Rev Immunol 2005, 5:21-30. Detailed review on the role of Wnt signaling in normal and malignant hematopoiesis.
39. Weerkamp F, Baert MR, Naber BA, et al.: Wnt signaling in the thymus is regulated by differential expression of intracellular signaling molecules. Proc Natl Acad Sci U S A 2006, 103:3322-3326.
40. Staal FJ, Meeldijk J, Moerer P, et al.: Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. Eur J Immunol 2001, 31:285-293.
41. Staal FJ, Clevers HC: Wnt signaling in the thymus. Curr Opin Immunol 2003, 15:204-208.
42. Giles RH, van Es JH, Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer [review]. Biochim Biophys Acta 2003, 1653:1-24.
43. Reya T, Clevers H: Wnt signalling in stem cells and cancer [review]. Nature 2005, 434:843-850.
44. • Guo Z, Dose M, Kovalovsky D, et al.: β-Catenin stabilization stalls the transition from Double-Positive to Single Positive stage and predisposes thymocytes to malignant transformation. Blood 2007, In press. First report to provide experimental evidence for deregulated Wnt signaling as a causative factor in (murine) T-ALL.
45. Roman-Gomez J, Cordeu L, Agirre X, et al.: Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007, 109:3462-3469.
46. Lewis HD, Leveridge M, Strack PR, et al.: Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Chem Biol 2007, 14:209-219.
47. Wong GT, Manfra D, Poulet FM, et al.: Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits B-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 2004, 279:12876-12882.
48. van Es JH, van Gijn ME, Riccio O, et al.: Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005, 435:959-963.
49. Emami KH, Nguyen C, Ma H, et al.: A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A 2004, 101:12682-12687.
50. van Vlierberghe P, Meijerink JP, Lee C, et al.: A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2006, 20:1245-1253.